Phase I evaluation and clinical pharmacology of tricyclic nucleoside 5'-phosphate using a weekly intravenous regimen von SCHILCHER, R. B, HAAS, C. D, SAMSON, M. K, YOUNG, J. D, BAKER, L. H

Volltext

Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous schedule von SCHILCHER, R. B, YOUNG, J. D, LEICHMAN, L. P, HAAS, C. D, BAKER, L. H

Volltext

Studies of hydroxyurea administered by continuous infusion. Toxicity, pharmacokinetics, and cell synchronization von Belt, Robert J., Haas, Charles D., Kennedy, James, Taylor, Sarah

Volltext

The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies von Toohill, Robert J., Duncavage, James A., Grossmam, Thomas W., Malin, Thomas C., Teplin, Robert W., Wilson, J. Frank, Byhardt, Roger W., Haas, Judith S., Cox, James D., Anderson, Tom, Holoye, Paul Y., Ritch, Paul S., Haas, Charles D., Libnoch, Joseph, Hoffmann, Raymond G., Fischer, Mary E.

Volltext

Epidermolysis bullosa dystrophica von Haas, Charles D.

Volltext

Phase I trial of indicine‐N‐oxide on two dose schedules von Taylor, Sarah, Belt, Robert J., Haas, Charles D., Hoogstraten, Barth

Volltext

Nafazatrom: in-vitro assessment of radiation and drug activity against animal and human cell lines von Haas, J S, Haas, C D, Kyle, G W

Volltext

Phase I evaluation of AT-125 single dose every three weeks von Taylor, S, Belt, R J, Joseph, U, Haas, C D, Hoogstraten, B

Volltext

Phase II evaluation of bleomycin. A Southwest Oncology Group study von Haas, Charles D., Coltman, Charles A., Gottlieb, Jeffrey A., Haut, Arthur, Luce, James K., Talley, Robert W., Samal, Bohumil, Wilson, Henry E., Hoogstraten, Barth

Volltext

Phase I evaluation of anguidine (diacetoxyscirpenol, NSC‐141537) von Goodwin, Wendall, Haas, Charles D., Fabian, Carol, Heller‐Bettinger, Irene, Hoogstraten, Barth

Volltext

Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial von Samson, M K, Haas, C D, Baker, L H, Cummings, G

Volltext

Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lung von TAPAZOGLOU, E, SAMSON, M. K, PAZDUR, R, HAAS, C. D, BAKER, L. H

Volltext

Nafazatrom: clonogenic in-vitro assessment of activity against human malignancies von Haas, C D, Kyle, G W, Crissman, J D, Schaldenbrand, M F

Volltext

Epidermolysis bullosa dystrophica: Report of a case von Haas, Charles D.

Volltext

Phase I evaluation of chlorozotocin: Single dose every six weeks von Taylor, Sarah, Belt, Robert J., Haas, Charles D., Stephens, Ronald L., Hoogstraten, Barth

Volltext

Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot study von Haas, C D, Fabian, C J, Stephens, R L, Kish, J

Volltext

Phase II clinical evaluation of AZQ in adenocarcinoma of the lung von DECKER, D. A, SAMSON, M. K, HAAS, C. D, BAKER, L. H

Volltext

Phase I and pharmacologic evaluation of nafazatrom in patients with cancer von Haas, C D, Baker, L H, Evans, Jr, L J

Volltext

Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group study von Haas, C D, McCracken, J D, Vaughn, C B, Stephens, R L, Bukowski, R M, Eyre, H J

Volltext

The Attitudes of Professional Federal Employees Toward Unions; A Study of Scientists and Engineers von Gilpin,Richard G, Haas,Charles D

Volltext bestellen